With a market cap of $145.9 billion, Stryker Corporation (SYK) is a global leader in medical technology. The company operates through its Orthopaedics and MedSurg & Neurotechnology segments, offering innovative products ranging from joint replacement implants to advanced surgical, neurovascular, and patient care solutions across more than 75 countries.
Shares of the Portage, Michigan-based company have underperformed the broader market over the past 52 weeks. SYK stock has increased 13.3% over this time frame, while the broader S&P 500 Index ($SPX) has gained 14.5%. Moreover, shares of the company have risen 7.3% on a YTD basis, compared to SPX's 9.2% return.
